CYP4V3 Activators refer to a specialized group of compounds that are involved in increasing the enzymatic activity of the CYP4V3 enzyme, a less characterized member of the cytochrome P450 family. Cytochrome P450 enzymes are a large and diverse group of heme-containing proteins that catalyze the oxidation of a wide variety of organic substrates, including lipids, steroid hormones, and xenobiotics. CYP4V3, like its relatives, is implicated in the metabolic processing of fatty acids. Activators of this enzyme would interact with CYP4V3 in a manner that enhances its natural catalytic function, possibly by stabilizing the enzyme in an active conformation, improving substrate binding, or increasing the rate of electron transfer within the catalytic cycle. The discovery of such activators typically necessitates a comprehensive screening process, employing biochemical assays to detect increases in enzyme activity in the presence of candidate molecules. This process would likely leverage the specific substrates and products of CYP4V3, alongside spectrophotometric or chromatographic methods, to accurately measure enzymatic activity.
Following the identification of molecules that can act as CYP4V3 activators, a detailed characterization of their interaction with the enzyme would be essential. This would involve kinetic studies to determine the impact of these activators on the rate of substrate turnover by CYP4V3, as well as binding studies to elucidate the affinity and stoichiometry of activator-enzyme interactions. Structural biology techniques such as X-ray crystallography or cryo-electron microscopy might be applied to visualize the binding of activators to the enzyme at the atomic level, revealing how they might induce conformational changes that lead to increased activity. Such structural insights would be vital for understanding the mechanism by which these activators enhance CYP4V3 function. Additionally, computational modeling and molecular dynamics simulations could provide further details on the interaction dynamics and predict the effects of chemical modifications on the efficacy of activators. Through these rigorous analyses, the role of CYP4V3 activators in modulating the enzyme's activity could be comprehensively understood, contributing to a deeper knowledge of the CYP4V3 enzyme itself and its place within the metabolic landscape of the cytochrome P450 family.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a retinoid, tretinoin may upregulate CYP4V3 expression through retinoid X receptor (RXR) pathways. | ||||||
Clofibric acid | 882-09-7 | sc-203000 sc-203000A | 10 g 50 g | $24.00 $40.00 | 1 | |
Clofibric acid, a fibrate, might induce CYP4V3 expression via PPARα activation, affecting lipid metabolism. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate is known to induce certain P450 enzymes by PPAR modulation, which could extend to CYP4V3. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPARγ agonist, rosiglitazone might affect CYP4V3 expression in the context of lipid metabolism. | ||||||
5-Aminolevulinic Acid Hydrochloride Salt | 5451-09-2 | sc-262399 sc-262399A sc-262399B sc-262399C | 1 g 5 g 25 g 100 g | $41.00 $110.00 $320.00 $1400.00 | 2 | |
Could theoretically increase CYP4V3 expression as it is involved in the heme synthesis pathway, which is related to P450 function. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
Known PPARα agonist which may enhance the expression of various P450 enzymes, possibly including CYP4V3. | ||||||
Silymarin group, mixture of isomers | 65666-07-1 | sc-301806 | 50 g | $325.00 | ||
The liver-protective agent silymarin may induce CYP4V3 by influencing hepatic enzyme levels and lipid metabolism. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
This monounsaturated fatty acid might modulate CYP4V3 as part of its broader effects on fatty acid metabolism. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $104.00 $431.00 | ||
EPA, an omega-3 fatty acid, may influence CYP4V3 expression through its roles in inflammation and lipid metabolism. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $38.00 | 13 | |
A flavonoid with potential effects on P450 enzymes, chrysin could affect CYP4V3 through metabolic pathways. | ||||||